Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002023043 | SCV002306235 | uncertain significance | Alpha-methylacyl-CoA racemase deficiency | 2022-10-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln89*) in the AMACR gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in AMACR cause disease. This variant is present in population databases (rs149566702, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with AMACR-related conditions. ClinVar contains an entry for this variant (Variation ID: 1512468). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |